Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients.

Clinical pharmacology and therapeutics - 1 Feb 2008

Kiser J J, Carten M L, Aquilante C L, Anderson P L, Wolfe P, King T M, Delahunty T, Bushman L R, Fletcher C V

Abstract excerpt

We determined the effects of lopinavir/ritonavir on tenofovir renal clearance. Human immunodeficiency virus-infected subjects taking tenofovir disoproxil fumarate (TDF) were matched on age, race, and gender and were enrolled into one of the following two groups: group 1: subjects taking TDF plus lopinavir/ritonavir plus other nucleoside reverse transcriptase inhibitors (NRTIs); group 2: subjects taking TDF plus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV Protease Inhibitors
Share to Lopinavir

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multidrug Resistance-Associated Protein 2

Share to Multidrug Resistance-Associated Proteins

Share to Organophosphonates

Share to Pyrimidinones

Share to Ritonavir

Share to Tenofovir

Source

Identifiers

PMID: 17597712
DOI: 10.1038/sj.clpt.6100269

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients.PMID 17597712Read ↗

Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines.Semantic proximity Read ↗

Pharmacogenetics of Tenofovir TreatmentSemantic proximity Read ↗

Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202.Semantic proximity Read ↗

Design and methods of the prevalence and pharmacogenomics of tenofovir nephrotoxicity in HIV-positive adults in south-western Nigeria study.Semantic proximity Read ↗

Tenofovir‐Related Nephrotoxicity: Case Report and Review of the LiteratureSemantic proximity Read ↗

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.Semantic proximity Read ↗

ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen.Semantic proximity Read ↗

Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults.Semantic proximity Read ↗

The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men.Semantic proximity Read ↗

Plasma and Intracellular Population Pharmacokinetic Analysis of Tenofovir in HIV-1-Infected PatientsSemantic proximity Read ↗

Tenofovir disoproxil fumarate-associated renal tubular dysfunction: noninvasive assessment of mitochondrial injury.Semantic proximity Read ↗

Tenofovir-induced renal tubular dysfunction in vertically HIV-infected patients associated with polymorphisms in ABCC2, ABCC4 and ABCC10 genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.